| Serial Number | 79394278 |
| Word Mark | MESOSIL |
| Filing Date | Thursday, March 28, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, October 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Antimicrobial or bioactive additives for preventing and inhibiting bacterial infections, proliferation and growth at the medical device-biological tissue interface or enhancing integration and performance at the medical device-biological tissue interface. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mesosil Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CA |
| Event Date | Event Description |
| Thursday, April 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, May 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 8, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 8, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, October 9, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, October 10, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, October 15, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, October 18, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, October 24, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 9, 2024 | REFUSAL PROCESSED BY IB |